stage I adult diffuse mixed cell lymphoma
Showing 9951 - 9975 of >10,000
Affect, Wellness, Psychological, Depressive Symptoms Trial in Montreal (A 4-week walking intervention)
Active, not recruiting
- Affect
- +6 more
- A 4-week walking intervention
-
Montreal, Quebec, CanadaDouglas Mental Health University Institute
May 25, 2023
Clinical Study of Stage IV Psoriasis in Children With Geleli
Not yet recruiting
- Plaque Psoriasis
- (no location specified)
Mar 26, 2023
Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Feasibility and Safety of a Low-field MRI, Acute Brain Injury, Extracorporeal Membrane Oxygenation Complication Trial in Kansas
Recruiting
- Feasibility and Safety of a Low-field MRI
- +2 more
- Hyperfine
-
Kansas City, MissouriChildren's Mercy Kansas City
Oct 7, 2023
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Peripheral T-cell Lymphoma Trial in Seoul (CHOP, fractionated ICED)
Recruiting
- Peripheral T-cell Lymphoma
- CHOP
- fractionated ICED
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Oct 21, 2020
Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)
Completed
- Multiple Sclerosis
- Biomarkers analysis
-
Rennes, FranceCHU Rennes
Mar 2, 2022
Myopathy Trial in Copenhagen (Exercise)
Recruiting
- Myopathy
- Exercise
-
Copenhagen, DenmarkNeuromuscular Research Unit, 3342
Oct 26, 2022
COVID-19 Trial in Fukuoka-shi (AZD7442 300 mg IM(male), AZD7442 600 mg IM (male), AZD7442 300 mg IV (male and female))
Completed
- COVID-19
- AZD7442 300 mg IM(male)
- +3 more
-
Fukuoka-shi, JapanResearch Site
Jun 24, 2022
Solid Tumor Trial in Singapore, Spain, United States (BNT142)
Recruiting
- Solid Tumor
- BNT142
-
Los Angeles, California
- +9 more
Jul 21, 2022
Targeting Staphylococci in Atopic Dermatitis
Not yet recruiting
- Atopic Dermatitis
- (no location specified)
Aug 12, 2022
Anal Canal Carcinoma Trial in France (Docetaxel, Cisplatin and 5-Fluorouracil)
Completed
- Anal Canal Carcinoma
- Docetaxel, Cisplatin and 5-Fluorouracil
-
Besançon, France
- +15 more
May 10, 2022
Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)
Not yet recruiting
- Non-hodgkin Lymphoma,B Cell
- CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
- (no location specified)
Feb 14, 2023
Stage III Gastric Cancer Trial in Nanjing (ONS)
Not yet recruiting
- Stage III Gastric Cancer
- ONS
-
Nanjing, Jiangsu, ChinaJinling Hospital, China
Jul 25, 2022
Menopause Related Conditions, Sarcopenia, Osteoporosis Postmenopausal Trial in Pamplona (Time Restricted Eating (TRE), Exercise,
Recruiting
- Menopause Related Conditions
- +3 more
- Time Restricted Eating (TRE)
- +2 more
-
Pamplona, Navarra, SpainUniversidad Pública de Navarra
Jun 12, 2023
Autism Spectrum Disorder Trial in Boston (Transcranial Photobiomodulation (tPBM), Placebo/ Sham)
Recruiting
- Autism Spectrum Disorder
- Transcranial Photobiomodulation (tPBM)
- Placebo/ Sham
-
Boston, MassachusettsMassachusetts General Hospital
May 2, 2022
Eye Diseases Trial in Guangzhou
Recruiting
- Eye Diseases
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
May 4, 2022
Breast Cancer Trial in Pittsburgh (Moderate-Intensity Aerobic Exercise Intervention)
Completed
- Breast Cancer
- Moderate-Intensity Aerobic Exercise Intervention
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Jan 10, 2023
Cervical Cancer Trial in Worldwide (Tisotumab Vedotin, Bevacizumab, Pembrolizumab)
Active, not recruiting
- Cervical Cancer
- Tisotumab Vedotin
- +3 more
-
Phoenix, Arizona
- +71 more
Jan 9, 2023
ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)
Not yet recruiting
- ALL
- +3 more
- Transcranial photobiomodulation (tPBM) - Mobile System
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 6, 2022
Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit Trial in Worldwide (Semi Quantitative Food Frequency Questionnaire
Recruiting
- Colorectal Cancer
- +3 more
- Semi Quantitative Food Frequency Questionnaire (SQFFQ)
-
Denver, Colorado
- +7 more
Feb 7, 2023
Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)
Not yet recruiting
- Carcinoma, Renal Cell
- Autologous alpha-DC1/TBVA vaccine
- Cabozantinib
-
Pittsburgh, PennsylvaniaUPMC Department of Urology
Jan 5, 2023